SMTL ID : 6ul8.1 (1 other biounit)

RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.68 Å

Oligo State

monomer

Ligands

1 x Q9J: (5S,6S,8R)-2-(1,3-benzothiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide(Non-covalent)

Q9J.1: 16 residues within 4Å: Chain A: S.21, V.28, A.41, K.43, E.62, L.66, L.75, I.89, T.91, E.92, Y.93, M.94, G.97, L.149, A.159, D.160 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.28, A:A.41, A:K.43, A:T.91 Hydrogen bonds: A:E.92, A:M.94, A:M.94, A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Haffner, C.D. et al., Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors. Acs Med.Chem.Lett. (2019)

Release Date

2019-12-04

Peptides

Receptor-interacting serine/threonine-protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Receptor-interacting serine/threonine-protein kinase 2

Related Entries With Identical Sequence